Splicing factor poly(rC)‐binding protein 1 is a novel and distinctive tumor suppressor

Authors:
Publisher website
Google Scholar
Abstract
A lot of evidence has been found on the link between tumorigenesis and the aberrant expression of splicing factors. A number of splicing factors have been reported to be either oncogenic or overexpressed in cancer cells. However, splicing factors can also play negative roles in tumorigenesis. In the current review, we focus on splicing factor poly(rC)‐binding protein 1 (PCBP1), a novel tumor suppressor that is characterized by downregulation in many cancer types and shows inhibition of tumor formation and metastasis. Notably, the messenger RNA levels of PCBP1 are not significantly decreased in most cancer types. In fact, PCBP1 protein is often degraded or shows a loss‐of‐function through phosphorylation in cancer cells. PCBP1 is highly homologous to its family member, PCBP2. Interestingly, PCBP2 appears to be an oncogenic splicing factor. A growing body of evidence has shown that PCBP1 regulates alternative splicing, translation, and RNA stability of many cancer‐related genes. Taking together, PCBP1 has distinctive tumor suppressive functions, and increasing PCBP1 expression may represent a new approach for cancer treatment.
Funding Information
  • National Natural Science Foundation of China (81571024)
  • National Natural Science Foundation of China (81271143)
  • National Natural Science Foundation of China (81470741)
  • Natural Science Foundation of Hubei Province (2016CFA067)

This publication has 82 references indexed in Scilit: